3.
Overall survival by treatment group and duration
| Treatment groups | Duration of HAD treatment | n | Censored | Median (95%CI) | 1 year survival rate (%) | 2 year survival rate (%) | Log-rank P |
| *P < 0.05 was considered statistically significant. | |||||||
| HAD group | < 4 wks | 13 | 2 | 12.0 months (3.8-20.2) |
46.2 | 23.1 | 0.134* |
| ≥4 wks | 17 | 4 | 14.0 months (4.9-23.1) |
52.9 | 28.2 | ||
| Combined therapy group | < 4 wks | 18 | 4 | 16.0 months (8.2-23.8) |
61.1 | 30.0 | |
| ≥4 wks | 26 | 9 | 23.0 months (10.6-35.4) |
76.9 | 47.8 | ||